checkAd
    Agile Therapeutics Registered (Old) Aktie
    0,1119
     
    USD
    -17,54 %
    -0,0238 USD
    Letzter Kurs 27.04.22 Nasdaq
    0,1132
     
    USD
    13.700 STK
    Geldkurs 26.04.22
    0,1138
     
    USD
    3.500 STK
    Briefkurs 26.04.22
    ISIN: US00847L1008 · WKN: A1135H · USA

    Neueste Nachrichten

    Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
    28.03.24 · globenewswire · Agile Therapeutics Registered (Old)
    Agile Therapeutics Announces Delisting from Nasdaq
    25.03.24 · globenewswire · Agile Therapeutics Registered (Old)
    Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024
    21.03.24 · globenewswire · Agile Therapeutics Registered (Old)
    Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024
    20.03.24 · globenewswire · Agile Therapeutics Registered (Old)
    Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
    13.03.24 · globenewswire · Agile Therapeutics Registered (Old)
    Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds
    22.02.24 · globenewswire · Agile Therapeutics Registered (Old)
    Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update
    15.02.24 · globenewswire · Agile Therapeutics Registered (Old)
    The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost
    23.01.24 · globenewswire · Agile Therapeutics Registered (Old)
    Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
    09.11.23 · globenewswire · Agile Therapeutics Registered (Old)
    Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023
    26.10.23 · globenewswire · Agile Therapeutics Registered (Old)
    Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
    04.10.23 · globenewswire · Agile Therapeutics Registered (Old)
    Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference
    05.09.23 · globenewswire · Agile Therapeutics Registered (Old)